Early Warning Signs of Multiple Sclerosis Identified in New Study
Recent research suggests that mental health issues may serve as early warning signs of multiple sclerosis (MS), often appearing long before traditional symptoms take hold. A study conducted at the University of British Columbia (UBC) and published in JAMA Network Open analyzed medical records from over 2,000 MS patients and compared them to a larger group of more than 10,000 people without the condition.
The findings revealed that individuals who would later develop MS often exhibited higher rates of mental health problems, increased visits to psychiatrists and general practitioners, and reported vague symptoms like fatigue and pain—sometimes up to 15 years prior to the onset of more recognizable MS symptoms.
Researchers highlighted that these insights indicate MS may have an earlier onset than previously believed, with mental health issues possibly acting as key indicators. MS affects approximately one million adults in the United States, damaging the protective myelin layer around nerve cells in the brain and spinal cord.
The study tracked patient visits over a 25-year span, identifying a rise in general practice visits starting 15 years before symptoms emerged. Visits to psychiatrists began to increase 12 years prior, while neurology and ophthalmology visits rose eight to nine years earlier, often due to symptoms like visual disturbances.
Emergency room and radiology visits surged three to five years before the onset of MS, peaking just before symptoms began. Notably, consultations with psychiatrists saw a dramatic increase of 159% before diagnosis, while general mental health visits rose 76%. This spike may indicate the body’s early immune changes related to MS.
While many individuals experience mental health issues and fatigue without developing MS, recognizing the “prodromal phase”—a time marked by subtle changes—could lead to quicker diagnoses and better health outcomes. Dr. Helen Tremlett, a lead researcher in the study, emphasized that mental health problems might be among the first signs of this early phase.
The research opens opportunities for identifying early indicators, lifestyle factors, and potential triggers linked to MS. This focus could not only help with MS detection but may also improve recognition of other conditions like Alzheimer’s disease.
Interestingly, the global prevalence of MS rose from 2.2 million to roughly 2.9 million cases between 2016 and 2021, largely influenced by public narratives from celebrities like Selma Blair and Montel Williams who have shared their experiences with the disease.
